ZA938825B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA938825B
ZA938825B ZA938825A ZA938825A ZA938825B ZA 938825 B ZA938825 B ZA 938825B ZA 938825 A ZA938825 A ZA 938825A ZA 938825 A ZA938825 A ZA 938825A ZA 938825 B ZA938825 B ZA 938825B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA938825A
Other languages
English (en)
Inventor
Sushil Chauhan
Gordon France
John Buehler
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA938825B publication Critical patent/ZA938825B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA938825A 1992-11-27 1993-11-25 Pharmaceutical compositions ZA938825B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224855A GB9224855D0 (en) 1992-11-27 1992-11-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA938825B true ZA938825B (en) 1995-05-25

Family

ID=10725759

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938825A ZA938825B (en) 1992-11-27 1993-11-25 Pharmaceutical compositions

Country Status (10)

Country Link
US (1) US5597844A (xx)
EP (1) EP0670722A1 (xx)
JP (1) JPH08503482A (xx)
KR (1) KR950703952A (xx)
CN (1) CN1095923A (xx)
AU (1) AU5563494A (xx)
CA (1) CA2149884A1 (xx)
GB (1) GB9224855D0 (xx)
WO (1) WO1994012180A1 (xx)
ZA (1) ZA938825B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7218194A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-alginate-antacid combinations
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1154479C (zh) * 1996-06-14 2004-06-23 协和发酵工业株式会社 口腔内快速崩解片剂
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
EP1364584B1 (en) * 1997-08-14 2005-10-26 Cadbury Adams USA LLC Taste modified hard confectionery compositions containing functional ingredients
US6242019B1 (en) * 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
IN186245B (xx) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
AU9496798A (en) 1997-09-19 1999-04-05 Shire Laboratories, Inc. Solid solution beadlet
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
WO1999033445A1 (en) * 1997-12-29 1999-07-08 The Procter & Gamble Company Tablet composition
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
FR2779651B1 (fr) * 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
BR9912533A (pt) * 1998-07-31 2002-02-13 Otsuka Pharma Co Ltd Composição farmacêutica tendo sabor melhorado
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
US6794411B1 (en) 1999-04-06 2004-09-21 Laboratoire Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
PT1183014E (pt) 1999-06-14 2003-12-31 Cosmo Spa Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
GB2398221B (en) * 2001-10-26 2006-04-12 John Kohnke Dosage system & dosage vehicle therefor
AUPS244002A0 (en) 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
AU2004294813A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
WO2005053655A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0417348A (pt) * 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CN1889933A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 由基于液体的工艺制备的阿奇霉素多颗粒剂型
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
MX2007004741A (es) 2004-10-21 2007-09-07 Eurand Pharmaceuticals Ltd Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
EP2506836B1 (en) 2009-12-02 2018-02-14 Adare Pharmaceuticals S.R.L. Fexofenadine microcapsules and compositions containing them
BR112013008834B1 (pt) * 2010-10-12 2021-08-03 Bayer Intellectual Property Gmbh Produto mastigável macio e seu processo de preparação
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
JP6039042B1 (ja) 2015-11-20 2016-12-07 株式会社スクウェア・エニックス 描画処理プログラム、描画処理装置、描画処理方法、発音処理プログラム、発音処理装置、及び、発音処理方法
AU2017345473A1 (en) * 2016-10-19 2019-04-18 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
CN109890368B (zh) * 2016-11-01 2021-12-21 强生消费者公司 包含组胺h2受体拮抗剂和抗酸剂的液体口服药物剂型
US20180140630A1 (en) * 2016-11-23 2018-05-24 M. Michael Wolfe Combination of an h2-receptor antagonist, antacid, and alginic acid to treat episodic heartburn
IT201800002625A1 (it) 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
CN112822998A (zh) * 2018-10-18 2021-05-18 强生消费者公司 新型剂型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
EP0587744B1 (en) * 1991-05-28 2003-07-16 McNEIL-PPC, Inc. Chewable drug-delivery composition
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
JPH08503482A (ja) 1996-04-16
US5597844A (en) 1997-01-28
KR950703952A (ko) 1995-11-17
GB9224855D0 (en) 1993-01-13
CA2149884A1 (en) 1994-06-09
WO1994012180A1 (en) 1994-06-09
CN1095923A (zh) 1994-12-07
EP0670722A1 (en) 1995-09-13
AU5563494A (en) 1994-06-22

Similar Documents

Publication Publication Date Title
GB9224855D0 (en) Pharmaceutical compositions
GB9308014D0 (en) Pharmaceutical compositions
HUT66864A (en) Pharmaceutical compositions
GB9319500D0 (en) Pharmaceutical composition
GB2272375B (en) Pharmaceutical composition
GB9209874D0 (en) Pharmaceutical compositions
GB9221707D0 (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
GB9226377D0 (en) Pharmaceutical compositions
GB9211276D0 (en) Pharmaceutical compositions
ZA924061B (en) Pharmaceutical composition
ZA935931B (en) Pharmaceutical composition
ZA931984B (en) Pharmaceutical composition
GB9222941D0 (en) Pharmaceutical compositions
GB9221800D0 (en) Pharmaceutical compositions
IL102579A0 (en) Pharmaceutical compositions
ZA935161B (en) Pharmaceutical compositions
GB9222942D0 (en) Pharmaceutical compositions
GB9203500D0 (en) Pharmaceutical compositions
GB9206412D0 (en) Pharmaceutical compositions
ZA925331B (en) Pharmaceutical compositions
GB9210226D0 (en) Pharmaceutical compositions
GB9211400D0 (en) Pharmaceutical compositions
GB9221447D0 (en) Pharmaceutical compositions